- Report
- May 2024
- 136 Pages
Global
From €5944EUR$6,499USD£5,060GBP
- Report
- May 2024
- 130 Pages
Global
From €5944EUR$6,499USD£5,060GBP
- Report
- May 2024
- 133 Pages
Global
From €5944EUR$6,499USD£5,060GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €457EUR$500USD£389GBP
Norvasc is a calcium channel blocker used to treat hypertension and angina. It is a popular drug in the cardiovascular drug market, as it is effective in reducing blood pressure and relieving chest pain. Norvasc is also used to treat coronary artery disease, and can be used in combination with other drugs to treat congestive heart failure. It is generally well-tolerated, with few side effects.
Norvasc is available in both generic and brand-name forms, and is widely prescribed by doctors. It is available in tablet form, and can be taken once or twice daily.
The cardiovascular drug market is highly competitive, with many different drugs available to treat various conditions. Norvasc is one of the most popular drugs in this market, due to its effectiveness and low side effects.
Some companies in the Norvasc market include Pfizer, Novartis, Merck, and GlaxoSmithKline. Show Less Read more